The Liquid Biopsy and Tumor Progression in Breast Cancer
91 – 100 of 121
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)
(
- Contribution to journal › Published meeting abstract
-
Mark
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection : The randomized controlled SENOMAC trial
(
- Contribution to journal › Article
-
Mark
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder : Association with tumor stage, lymph node metastases, FDG-PET findings, and survival
(
- Contribution to journal › Article
-
Mark
Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy
(
- Contribution to journal › Article
-
Mark
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
(
- Contribution to journal › Article
-
Mark
Myoepithelium assessment with p63 immunostaining in formalinfixed paraffin-embedded breast cancer tissue pre-treated with RNA-later
(
- Contribution to journal › Published meeting abstract
-
Mark
Quality of up to 35 years old archival breast cancer tissue in paraffinblocks for estrogen receptor evaluation
(
- Contribution to journal › Published meeting abstract
-
Mark
Receptor tyrosine kinases and circulating tumor cells as new prognostic biomarkers in breast cancer with special focus on TNBC
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Claudin-4 expression is associated with progression free survival in ovarian cancer, but not with chemotherapy response
(
- Contribution to journal › Article
-
Mark
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
(
- Contribution to journal › Article